Zurück zu Kognition
Kognition

Nootropic StacksStudienlage & Dosis

Kombinationen, Synergien, Sicherheit und Tracking.

Studien zuletzt aktualisiert

Studienlage in Zahlen

Studien gesamt
589
Mit Abstract
49
Meta / Systematic / RCT
145
Häufig zitiert
50
Erscheinungsjahre
1991–2026

Nootropic Stacks im Kontext von Kognition

Dieses Thema ist Teil unserer Welt „Kognition". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Kognition

Top-Studien zu Nootropic Stacks

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

  1. Cholinesterase inhibitors for Alzheimer's disease.

    Cochrane Database Syst Rev2006n=13Meta-Analysis200 einflussreiche Zitationen

    <h4>Background</h4>Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line…

    Befund: Donepezil, galantamine, and rivastigmine improved cognitive function in people with mild, moderate, or severe dementia due to Alzheimer's disease.

  2. Antipsychotic Drugs and Cognitive Function: A Systematic Review and Network Meta-Analysis.

    JAMA Psychiatry2025n=952meta200 einflussreiche Zitationen

    IMPORTANCE: Cognitive deficits are a substantial part of the symptoms of schizophrenia spectrum disorders (SSDs) and contribute heavily to the burden of disease. Antipsychotic drugs are not cognitive enhancers, but due to their different…

  3. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.

    J Alzheimers Dis2014Meta-Analysis136 einflussreiche Zitationen

    <h4>Background</h4>The role of currently available drugs for Alzheimer's disease (AD) has been controversial, with some national formularies restricting their use, and health economists questioning whether the small clinical effects are…

    Befund: Memantine had no effect on the Clinicians' Global Impression of Change scale.

  4. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.

    Pharmacol Res2010Systematic Review97 einflussreiche Zitationen

    The term neuroenhancement refers to improvement in the cognitive, emotional and motivational functions of healthy individuals through, inter alia, the use of drugs. Of known interventions, psychopharmacology provides readily available…

  5. The effect of curcumin on cognition in Alzheimer's disease and healthy aging: A systematic review of pre-clinical and clinical studies.

    Brain Res2019Systematic Review90 einflussreiche Zitationen

    Alzheimer's disease constitutes a growing cause of cognitive impairment in aging population. Given that current treatments do not produce the desired therapeutic effects, the need for finding alternative biological and pharmacological…

  6. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis.

    J Alzheimers Dis2015Meta-Analysis76 einflussreiche Zitationen

    <h4>Background</h4>In the past 20 years, substantial evidence from laboratory and epidemiologic studies have suggested that anti-inflammatory medications could defer or prevent the occurrence of Alzheimer's disease (AD). However, several…

  7. Donepezil for dementia due to Alzheimer's disease.

    Cochrane Database Syst Rev2006n=527Meta-Analysis75 einflussreiche Zitationen

    <h4>Background</h4>Alzheimer's disease is the most common cause of dementia in older people. One of the aims of therapy is to inhibit the breakdown of a chemical neurotransmitter, acetylcholine, by blocking the relevant enzyme. This can be…

  8. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.

    Am J Psychiatry2015n=44Meta-Analysis75 einflussreiche Zitationen

    <h4>Objective</h4>The authors examined research on effects, costs, and patient and caregiver views of pharmacological management strategies for Lewy body dementia.<h4>Method</h4>Studies were identified through bibliographic databases,…

  9. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.

    CNS Drugs2015n=1.346.176Systematic Review65 einflussreiche Zitationen

    <h4>Background</h4>Chronic hypertension, particularly midlife high blood pressure, has been associated with an increased risk for cognitive decline and dementia. In this context, antihypertensive drugs might have a preventive effect, but…

  10. Cognition and gut microbiota in schizophrenia spectrum and mood disorders: A systematic review.

    Neurosci Biobehav Rev2024n=10Systematic Review65 einflussreiche Zitationen

    FRILEUX, M., BOLTRI M. and al. Cognition and Gut microbiota in schizophrenia spectrum and mood disorders: a Systematic Review. NEUROSCI BIOBEHAV REV (1) 2024 Schizophrenia spectrum disorders and major mood disorders are associated with…

Häufige Fragen

Was sagt die Studienlage zu Nootropic Stacks?
Donepezil, galantamine, and rivastigmine improved cognitive function in people with mild, moderate, or severe dementia due to Alzheimer's disease.
Welche Dosierung wurde in den Studien untersucht?
• Cholinesterase inhibitors (donepezil, galantamine, rivastigmine) (Recommended dose) • Antipsychotic drugs (various classes, including haloperidol, fluphenazine, clozapine, adrenergic/low dopamine, serotonergic/dopaminergic, muscarinic, and dopaminergic agents) • Donepezil, galantamine, rivastigmine, and memantine (Donepezil 5 mg daily and 10 mg daily; galantamine 24 mg daily and 32 mg daily; memantine 20 mg daily)
Für welche Population gilt die Evidenz?
Die meisten Studien untersuchten: unknown.
Gibt es Sicherheitshinweise zu Nootropic Stacks?
• ChEI treatment had more adverse events overall than placebo. • Nausea, vomiting, and diarrhoea were more frequent with ChEIs. • About 29% discontinued ChEIs due to adverse events vs 18% with placebo. • Donepezil had fewer adverse events than rivastigmine in one comparison.

Verwandte Artikel

Blog

Nootropic Stacks: Wirkung & Studienlage – Was belegt ist

Evidenzbasierter Überblick zu Nootropic Stacks: Was ist durch Studien gut belegt, was bleibt unsicher – und welche Lifestyle-Hebel vorher greifen sollten.

Weitere Themen in Kognition

Bacopa Monnieri

Gedächtnis, Bacosides, Langzeit-Wirkung und Toleranz.

Acetyl-L-Carnitine (ALCAR)

Mitochondrien, Neuroprotektion und Energie-Stoffwechsel.

Acetylcholin

Gedächtnis, Aufmerksamkeit, REM-Schlaf, Cholin-Quellen.

Active Recall

Abrufen statt Wiederlesen — wissenschaftlich überlegene Lernmethode.

Alpha-GPC

Cholin-Quelle, Acetylcholin und kognitive Performance.

Binaurale Beats

Auditive Frequenz-Stimulation — Wirknachweise gemischt.

Blut-Hirn-Schranke

Selektive Durchlässigkeit, Substanzdurchtritt, Entzündungs-Permeabilität.

Brain Fog

Multifaktoriell: Schlaf, Blutzucker, Entzündung, Schilddrüse, Long-Covid.

Koffein

Adenosin-Rezeptor-Antagonist, Toleranz, Timing, Halbwertszeit, Genetik.

Citicoline (CDP-Choline)

Phospholipid-Synthese, ADHS und neurologische Anwendungen.

Kreatin

Mehr als Sport: Gedächtnis, Schlafentzug, vegane Defizite.

Deep Work

Konzentrierte, ablenkungsfreie Arbeit als trainierbare Fähigkeit.

Dopamin

Motivation, Belohnung, Bewegung, Lernen — zentrale Reward-Chemie.

Dopamin-Detox

Beliebter Trend ohne starke wissenschaftliche Basis — was sinnvoll bleibt.

Bewegung & Lernen

BDNF, Hippocampus, kognitive Reserve — Sport macht klüger.

Flow

Optimaler Bewusstseinszustand bei voller Vertiefung — Bedingungen und Trigger.

Ginkgo Biloba

Mikrozirkulation, Gedächtnis und Demenz-Wechselwirkungen.

Glukose vs. Ketone

Hirn-Energiequellen, ketogene Adaption, kognitive Effekte.

Histamin

Wachheit, Allergie, Histamin-Intoleranz und Brain Fog.

L-Theanin

Alpha-Wellen, Entspannung ohne Sedierung, Koffein-Synergie.

Verwandte Themen aus anderen Welten

Mental

Koffein & Angst

Adenosin-Antagonismus, individuelle Sensitivität, Cut-off-Strategien.

Mental

EMDR / Trauma Therapy

PTSD, Augenbewegung und Studien-Wirksamkeit.

Mental

Lavendel

Silexan-Studien, oral und olfaktorisch — Anxiolyse mit guter Sicherheit.

Mental

Polyvagal-Theorie

Populär, aber wissenschaftlich umstritten — Stärken und Schwächen.

Mental

Somatische Therapie

Körperorientierte Trauma-Arbeit — Somatic Experiencing u.a.

Peptide

Verabreichung

Subkutan, intramuskulär, nasal, oral, topisch — Bioverfügbarkeit und Sicherheit.